Cardiovascular Disease Doctors in Greenville, MS Accepting Medicare

3 Cardiovascular Disease doctors found. Showing 1 - 3

John L Herzog Sr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1421 E Union St, Greenville, MS 38703 Phone: 662-335-0183    Fax: 662-335-7184

Dr. Kathleen Anne Mansour, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1513 E Union St, Greenville, MS 38703 Phone: 662-378-9191    Fax: 662-378-5353

Kenneth A Hahn, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1306 Hospital St, Greenville, MS 38703 Phone: 662-334-9712    Fax: 662-332-9703

News Archive

Study examines long-term effect of TBI on women's reproductive health

After a brain injury, women often ask how the injury will affect their fertility, pregnancy and postpartum health. Now a new study provides some much-needed answers. Published in the June issue of the Journal of Women's Health, the study is the most comprehensive investigation to date of women's health issues after traumatic brain injury.

Phase II ALSTAR trial: Talampanel is safe for ALS patients

Teva Pharmaceutical Industries Ltd. today announced results from the Phase II ALSTAR trial. The trial was designed to assess efficacy, safety and tolerability of Talampanel (a selective AMPA antagonist) in reducing disease-related functional deterioration in Amyotrophic Lateral Sclerosis patients.

Practical changes in school infrastructure can provide better environments for disabled students

NJIT Research Architect B. Lynn Hutchings believes that by making a few practical, effective and relatively inexpensive changes to school buildings, they can become better environments for students with severe physical, intellectual, and sensory disabilities.

Also in global health news: Kenya HIV/AIDS; Uganda bill; water project in Philippines; U.N. appeal for Yemen

U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).

Serological assays for SARS-CoV-2 can guide reintroduction of workforce if used with caution

With several high-quality serological assays for SARS-CoV-2 now available, the key challenge in using them to help people return to "normal life," write Florian Krammer and Viviana Simon in this Perspective, will be to apply them in a strategic manner - one that considers their unique sensitivity and specificity levels, acknowledges the questions they don't yet answer, and more.

Read more Medical News

› Verified 8 days ago